We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+12.18%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$323M
AUM Growth
+$29.7M
Cap. Flow
-$2.92M
Cap. Flow %
-0.9%
Top 10 Hldgs %
27.07%
Holding
107
New
5
Increased
33
Reduced
42
Closed
1

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$1.1M
2
WU icon
Western Union
WU
+$968K
3
DIS icon
Walt Disney
DIS
+$887K
4
AMZN icon
Amazon
AMZN
+$510K
5
COP icon
ConocoPhillips
COP
+$385K

Sector Composition

Rank Sector Weight
1 Healthcare 15.08%
2 Technology 12.11%
3 Industrials 12.04%
4 Consumer Staples 11.41%
5 Consumer Discretionary 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
51
iShares Core S&P Mid-Cap ETF
IJH
$124B
$2.51M 0.78%
51,805
+4,005
+8% +$193K
CTAS icon
52
Cintas
CTAS
$81.6B
$2.5M 0.77%
22,120
MGA icon
53
Magna International
MGA
$18.2B
$2.39M 0.74%
42,610
-3,830
-8% -$215K
VTI icon
54
Vanguard Morningstar Total Stock Market ETF
VTI
$670B
$2.37M 0.73%
12,380
AMZN icon
55
Amazon
AMZN
$3.06T
$2.26M 0.7%
26,871
-5,166
-16% -$510K
IBB icon
56
iShares Biotechnology ETF
IBB
$9.18B
$2.15M 0.67%
16,396
-305
-2% -$39.4K
VB icon
57
Vanguard Morningstar Small-Cap ETF
VB
$80.7B
$2.12M 0.66%
11,550
-61
-0.5% -$11.3K
HYG icon
58
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$2.09M 0.65%
28,449
+320
+1% +$23.6K
BBH icon
59
VanEck Biotech ETF
BBH
$398M
$2.04M 0.63%
12,761
USB icon
60
US Bancorp
USB
$99.6B
$1.99M 0.62%
45,626
+2,695
+6% +$115K
IAU icon
61
iShares Gold Trust
IAU
$62.9B
$1.86M 0.58%
53,838
JNJ icon
62
Johnson & Johnson
JNJ
$613B
$1.73M 0.54%
9,795
+22
+0.2% +$3.8K
HYD icon
63
VanEck High Yield Muni ETF
HYD
$4.42B
$1.64M 0.51%
32,363
+1,000
+3% +$50.5K
LLY icon
64
Eli Lilly
LLY
$1,000B
$1.62M 0.5%
4,433
-40
-0.9% -$14.2K
CVX icon
65
Chevron
CVX
$385B
$1.61M 0.5%
8,983
-80
-0.9% -$14K
PFE icon
66
Pfizer
PFE
$143B
$1.22M 0.38%
23,905
+73
+0.3% +$3.5K
VEU icon
67
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
$1.11M 0.34%
22,134
+1,100
+5% +$53.4K
SYK icon
68
Stryker
SYK
$131B
$1.06M 0.33%
4,354
GOOG icon
69
Alphabet (Google) Class C
GOOG
$4.56T
$1.05M 0.32%
11,820
+40
+0.3% +$3.82K
VEA icon
70
Vanguard FTSE Developed Markets ETF
VEA
$230B
$888K 0.27%
21,165
-800
-4% -$32.4K
PAYX icon
71
Paychex
PAYX
$41.9B
$886K 0.27%
7,675
CAT icon
72
Caterpillar
CAT
$382B
$848K 0.26%
3,542
ORCL icon
73
Oracle
ORCL
$409B
$840K 0.26%
10,278
+67
+0.7% +$5.09K
PFF icon
74
iShares Preferred and Income Securities ETF
PFF
$13.3B
$715K 0.22%
23,446
+3,235
+16% +$101K
IBM icon
75
IBM
IBM
$213B
$633K 0.2%
4,496

Similar funds

Boston Research & Management's Q4 2022 Portfolio in Review

As of Q4 2022, Boston Research & Management held 107 positions worth $323M, up 10% from $294M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Research & Management's Q4 2022 filing shows 5 new, 33 increased, 42 reduced and 1 closed positions. Its largest new stake was Shell: 6,644 shares worth $378K. The largest sale was Verizon, an estimated $1.1M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Boston Research & Management's largest Q4 2022 buy was Shell: 6,644 shares worth $378K.
  • Boston Research & Management added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $1.71M increase.
  • Boston Research & Management's biggest Q4 2022 reduction was Verizon, cutting an estimated $1.1M.
  • Boston Research & Management fully exited Western Union in Q4 2022, selling an estimated $968K.
  • Boston Research & Management's ten largest holdings make up 27% of its $323M portfolio in Q4 2022.
  • Boston Research & Management opened 5 new positions and closed 1 in Q4 2022.
  • Boston Research & Management's portfolio value rose 10% quarter-over-quarter to $323M.

Based on Boston Research & Management's 13F filing for Q4 2022, filed 13 Feb 2023.